Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; and products for surgical treatment of tumors or vascular diseases, such as aneurysms. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Phone+49-3641-2200
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees3,048
OptionableNot Optionable
Carl Zeiss Meditec (ETR:AFX) Frequently Asked Questions
What is Carl Zeiss Meditec's stock symbol?
Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."
What price target have analysts set for AFX?
9 brokerages have issued 12-month price targets for Carl Zeiss Meditec's stock. Their forecasts range from €58.00 to €92.00. On average, they expect Carl Zeiss Meditec's stock price to reach €72.94 in the next year. This suggests that the stock has a possible downside of 5.6%. View Analyst Price Targets for Carl Zeiss Meditec.
What is the consensus analysts' recommendation for Carl Zeiss Meditec?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last year. There are currently 3 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Carl Zeiss Meditec.
Has Carl Zeiss Meditec been receiving favorable news coverage?
Media headlines about AFX stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Carl Zeiss Meditec earned a daily sentiment score of 1.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days.
Who are some of Carl Zeiss Meditec's key competitors?
Some companies that are related to Carl Zeiss Meditec include BioMark Diagnostics (BUX), BioNano Genomics (BNGOU), Breathtec Biomedical (BTH), Cambridge Cognition (COG), Carl Data Solutions (CRL), Co-Diagnostics (CODX), Deepmatter Group (DMTR), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH), Genedrive (GDR), MaxCyte (MXCT), Medical Imaging (MEDD), Oncimmune (ONC), Parallax Health Sciences (PRLX) and Profound Medical (PRN).
Who are Carl Zeiss Meditec's key executives?
Carl Zeiss Meditec's management team includes the folowing people:
- Dr. Ludwin Monz, Pres, CEO & Chairman of Management Board (Age 56)
- Mr. Justus Felix Wehmer, CFO & Member of the Management Board (Age 54)
- Mr. Jan Willem de Cler, Head of Surgical Ophthalmology & Member of Management Board
- Mr. Sebastian Frericks, Director of Investor Relations
- Mr. Martin Wiechmann, Head of the Planetarium Bus. Unit
What is Carl Zeiss Meditec's stock price today?
One share of AFX stock can currently be purchased for approximately €77.30.
What is Carl Zeiss Meditec's official website?
How can I contact Carl Zeiss Meditec?
Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The company can be reached via phone at +49-3641-2200.
MarketBeat Community Rating for Carl Zeiss Meditec (ETR AFX)
MarketBeat's community ratings are surveys of what our community members think about Carl Zeiss Meditec and other stocks. Vote "Outperform" if you believe AFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
